Press Room

Share

FILTER BY:

April 16, 2026

Guam Cancer Advocates Applaud Adoption of HPV Vaccine Requirement

Advocates, including cancer patients, survivors and caregivers with the American Cancer Society Cancer Action Network (ACS CAN) applaud the Guam Department of Public Health and Social Services for updating the school health requirements to include the Human Papillomavirus (HPV) vaccine for middle

April 16, 2026

NASHVILLE, Tenn. – The Tennessee Senate unanimously passed a bill to expand coverage of biomarker testing on Thursday, April 16, sending it to the desk of Gov. Bill Lee.

April 16, 2026

WASHINGTON, DC – APRIL 16, 2026 – The American Cancer Society Cancer Action Network (ACS CAN) released a new report today showing the scope of cancer disparities in the United States and recommended local, state and federal policies that can help reduce them. Cancer Disparities: An American Cancer Society Cancer Action Network Chartbook examines disparities in cancer screening, prevention and early detection, disparities in cancer incidence, mortality and survival, as well as disparities in access to health coverage.

April 15, 2026

Cancer Advocates Applaud the Senate’s Passage of Biomarker Testing Legislation, Ensuring Illinoisans Have Better Access to Personalized Care. 

April 14, 2026

BOISE, Idaho –– More Idaho cancer patients will have easier and more affordable access to oral chemotherapy drugs thanks to House Bill 648, passed by the Idaho Legislature and signed into law this session by Gov. Brad Little.

Media Contacts

Emily Burr
Director, Media Advocacy
Medicaid, Patient Navigation
Trista Hargrove
Director, Media Advocacy
Health Equity
Josh Wilson
Senior Manager, Media Advocacy
Cancer Prevention, Tobacco Control

Media Campaigns

ACS CAN’s newest campaign highlights the need to build on proven progress in groundbreaking research with sustained funding increase for the National Institutes of Health and National Cancer Institute.

ACS CAN urges Congress to Fight Cancer and Make Time, literally, for more of life’s moments for patients and survivors by prioritizing cancer research.